The effect of reducing insulin degrading enzyme in HEPG2 cells on activation of insulin receptor, IRS-1 and SHC by tyrosine phosphorylation

The effect of reducing insulin degrading enzyme in HEPG2 cells on activation of insulin receptor, IRS-1 and SHC by tyrosine phosphorylation

Bibliographic Details
Main Author:	Abhyankar, Lalita
Language:	en
Published:	The University of Arizona. 2009
Online Access:	http://hdl.handle.net/10150/192259

Similar Items

Insulin receptor has tyrosine kinase activity toward Shc in rat liver
by: E.V. Páez-Espinosa, et al.
Published: (1998-11-01)

Novel idebenone analogs block Shc’s access to insulin receptor to improve insulin sensitivity
by: ChunKiu Hui, et al.
Published: (2020-12-01)

Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation
by: James Stephen R, et al.
Published: (2004-11-01)

Redox regulation of insulin degradation by insulin-degrading enzyme.
by: Crystal M Cordes, et al.
Published: (2011-01-01)

Targeting Insulin-Degrading Enzyme in Insulin Clearance
by: Malcolm A. Leissring, et al.
Published: (2021-02-01)

Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
by: Carlos M. González-Casimiro, et al.
Published: (2021-01-01)

Modulation of Obesity and Insulin Resistance by the Redox Enzyme and Adaptor Protein p66<sup>Shc</sup>
by: Stefano Ciciliot, et al.
Published: (2019-02-01)

Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
by: Malcolm A Leissring, et al.
Published: (2010-05-01)

Cytochrome C is tyrosine 97 phosphorylated by neuroprotective insulin treatment.
by: Thomas H Sanderson, et al.
Published: (2013-01-01)

Ligand binding affinity at the insulin receptor isoform A (IR-A) and subsequent IR-A tyrosine phosphorylation kinetics are important determinants of mitogenic biological outcomes.
by: Harinda eRajapaksha, et al.
Published: (2015-07-01)

Chromium-insulin reduces insulin clearance and enhances insulin signaling by suppressing hepatic insulin-degrading enzyme and proteasome protein expression in KKAy mice
by: Zhong Q Wang, et al.
Published: (2014-07-01)

Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme
by: Qiuchen Zheng, et al.
Published: (2021-08-01)

An Extended Polyanion Activation Surface in Insulin Degrading Enzyme.
by: Eun Suk Song, et al.
Published: (2015-01-01)

Insulin-Degrading Enzyme: Paradoxes and Possibilities
by: Malcolm A. Leissring
Published: (2021-09-01)

Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice
by: He J, et al.
Published: (2019-11-01)

The insulin-degrading enzyme as a link between insulin and neuropeptides metabolism
by: Dorota Wacławczyk, et al.
Published: (2021-01-01)

The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease
by: Claude Messier, et al.
Published: (2005-01-01)

Regulation of insulin receptors by serine/threonine phosphorylation
by: Pillay, Tahir Shoyeb
Published: (1990)

Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
by: Zhening Zhang, et al.
Published: (2018-03-01)

Studies on the insulin receptor tyrosine-specific protein kinase
by: O'Brien, Richard Mark
Published: (1987)

Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.
by: Diego Sbardella, et al.
Published: (2015-01-01)

QiDiTangShen Granules Reduced Diabetic Kidney Injury by Regulating the Phosphorylation Balance of the Tyrosine and Serine Residues of Insulin Receptor Substrate 1
by: Xue Gao, et al.
Published: (2018-01-01)

Insulin Metabolism and Protein Degradation by HEPG2 Hepatocytes Treated with HIV-Protease Inhibitors
by: Tsui, Brian
Published: (2007)

Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor*
by: Emma M. Allister, et al.
Published: (2008-10-01)

Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain.
by: Karyn J Catalano, et al.
Published: (2014-01-01)

Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation.
by: Eun Suk Song, et al.
Published: (2012-01-01)

Insulin Phosphorylates Tyrosine Residue 464 of Tub and Translocates Tubby into the Nucleus in HIRcB Cells
by: Jin Wook Kim, et al.
Published: (2014-06-01)

Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
by: Samer O Abdul-Hay, et al.
Published: (2011-01-01)

Protein phosphorylation and insulin secretion
by: Brocklehurst, K. W.
Published: (1983)

Role of Receptor Protein Tyrosine Phosphatases (RPTPs) in Insulin Signaling and Secretion
by: Julio Sevillano, et al.
Published: (2021-05-01)

Resveratrol Sustains Insulin-Degrading Enzyme Activity toward Aβ42
by: Claire A. Krasinski, et al.
Published: (2018-10-01)

JNK downregulation improves olanzapine-induced insulin resistance by suppressing IRS1Ser307 phosphorylation and reducing inflammation
by: Huqun Li, et al.
Published: (2021-10-01)

Studies concerning the iodination of tyrosine in insulin
by: Harrison, D. M.
Published: (1970)

Data on metabolic profile of insulin-degrading enzyme knockout mice
by: Diego O. Borges, et al.
Published: (2019-08-01)

Triterpenoid Saponins from Stauntonia chinensis Ameliorate Insulin Resistance via the AMP-Activated Protein Kinase and IR/IRS-1/PI3K/Akt Pathways in Insulin-Resistant HepG2 Cells
by: Xin Hu, et al.
Published: (2014-06-01)

APPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor
by: Jiyoon Ryu, et al.
Published: (2014-05-01)

Mechanism of Electroacupuncture Regulating IRS-1 Phosphorylation in Skeletal Muscle to Improve Insulin Sensitivity
by: Shanshan Song, et al.
Published: (2021-01-01)

Regulation of insulin receptor signal transduction by protein serine/threonine phosphorylation
by: Coghlan, Matthew Paul
Published: (1994)

Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD.
by: Grazia Tundo, et al.
Published: (2012-01-01)

Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
by: Bilal Çakir, et al.
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_8t3jf194np6sfum82fhfqr5u0a